Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3836 participants.

Also called NCT07644234

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 3,836 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07644234
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07644234. Randomized; no masking; primary purpose prevention. Start 2026-06 (anticipated); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
Acronym
PATH STROKE D
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Aspirin
Lead sponsor
Sichuan Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct07644234
Content hash
3c79289e70c76aaec854fc2ebd043361877c7cc0a2f4b2af8ec22d23377607e9